Sterling Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 31, 2008, inter alia, has recommended 50% (Rs 0.50 per equity shares of FV of Rs 1/-) dividend on the equity shares for the financial year ended December 31, 2007 subject to approval of the members.
This entry was posted
on Monday, March 31st, 2008 at 11:30 am and is filed under News.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
